{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T20:11:55Z","timestamp":1789071115496,"version":"build-2803163510"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100020595","name":"Taiwan Ministry of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST 111-2314-B-040 -009 -MY3"],"award-info":[{"award-number":["MOST 111-2314-B-040 -009 -MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ejphar.2026.179306","type":"journal-article","created":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T06:43:54Z","timestamp":1788331434000},"page":"179306","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["ASC-J9 attenuates the metastatic potential of oral cancer cells by downregulating the STAT3\/ITGB8 signaling pathway"],"prefix":"10.1016","volume":"1033","author":[{"given":"Pei-Ni","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiao-Wen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Ting","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0365-7927","authenticated-orcid":false,"given":"Shun-Fa","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Chao","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2026.179306_bib1","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1080\/15384101.2016.1259037","article-title":"STAT3-mediated SMAD3 activation underlies Oncostatin M-induced Senescence","volume":"16","author":"Bryson","year":"2017","journal-title":"Cell Cycle"},{"key":"10.1016\/j.ejphar.2026.179306_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14225519","article-title":"CLEFMA induces the apoptosis of oral squamous carcinoma cells through the regulation of the P38\/HO-1 signalling pathway","volume":"14","author":"Chen","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ejphar.2026.179306_bib3","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.21873\/anticanres.16265","article-title":"Fluoxetine inhibits STAT3-mediated survival and invasion of Osteosarcoma cells","volume":"43","author":"Chen","year":"2023","journal-title":"Anticancer Res."},{"key":"10.1016\/j.ejphar.2026.179306_bib4","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/s41568-018-0038-z","article-title":"Every step of the way: integrins in cancer progression and metastasis","volume":"18","author":"Hamidi","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejphar.2026.179306_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23105549","article-title":"ASC-J9 blocks cell proliferation and extracellular matrix production of keloid fibroblasts through inhibiting STAT3 signaling","volume":"23","author":"Hong","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2026.179306_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2024.149965","article-title":"Transforming growth factor-\u03b2 signals promote progression of squamous cell carcinoma by inducing epithelial-mesenchymal transition and angiogenesis","volume":"714","author":"Ibi","year":"2024","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2026.179306_bib7","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12929-022-00824-z","article-title":"MicroRNA-485-5p targets keratin 17 to regulate oral cancer stemness and chemoresistance via the integrin\/FAK\/Src\/ERK\/\u03b2-catenin pathway","volume":"29","author":"Jang","year":"2022","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.ejphar.2026.179306_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/cells11193131","article-title":"STAT3 and its targeting inhibitors in oral squamous cell carcinoma","volume":"11","author":"Jiang","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.ejphar.2026.179306_bib9","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/s41580-022-00531-5","article-title":"Organization, dynamics and mechanoregulation of integrin-mediated cell-ECM adhesions","volume":"24","author":"Kanchanawong","year":"2023","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejphar.2026.179306_bib10","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.31557\/APJCP.2022.23.6.2079","article-title":"Detection of epithelial-mesenchymal transition markers in high grade bladder cancer and special variants of urothelial carcinoma","volume":"23","author":"Khalil","year":"2022","journal-title":"Asian Pac. J. Cancer Prev. APJCP"},{"key":"10.1016\/j.ejphar.2026.179306_bib11","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s12943-024-02069-w","article-title":"Cancer, metastasis, and the epigenome","volume":"23","author":"Kiri","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ejphar.2026.179306_bib12","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.ajpath.2012.10.029","article-title":"New therapeutic approach to suppress castration-resistant prostate cancer using ASC-J9 via targeting androgen receptor in selective prostate cells","volume":"182","author":"Lai","year":"2013","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ejphar.2026.179306_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/15384101.2021.1919829","article-title":"Circ_0017956 promotes the proliferation and metastasis of non-small cell lung cancer through regulating miR-515-5p\/ITGB8 axis","author":"Li","year":"2021","journal-title":"Cell Cycle"},{"key":"10.1016\/j.ejphar.2026.179306_bib15","doi-asserted-by":"crossref","first-page":"818","DOI":"10.7150\/ijbs.91786","article-title":"IGF2BP2 promotes cell invasion and epithelial-mesenchymal transition through src-mediated upregulation of EREG in oral cancer","volume":"20","author":"Lin","year":"2024","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.ejphar.2026.179306_bib14","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.canlet.2018.02.007","article-title":"ASC-J9(\u00ae) suppresses prostate cancer cell invasion via altering the sumoylation-phosphorylation of STAT3","volume":"425","author":"Lin","year":"2018","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ejphar.2026.179306_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2023.108458","article-title":"Integrins in cancer: emerging mechanisms and therapeutic opportunities","volume":"247","author":"Liu","year":"2023","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2026.179306_bib16","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.3892\/ijo.2014.2310","article-title":"JAK\/STAT3 signaling is required for TGF-\u03b2-induced epithelial-mesenchymal transition in lung cancer cells","volume":"44","author":"Liu","year":"2014","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.ejphar.2026.179306_bib17","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/s41419-022-04959-7","article-title":"Paradoxical role of \u03b28 integrin on angiogenesis and vasculogenic mimicry in glioblastoma","volume":"13","author":"Liu","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejphar.2026.179306_bib19","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.devcel.2019.04.010","article-title":"Epithelial-Mesenchymal plasticity in cancer progression and metastasis","volume":"49","author":"Lu","year":"2019","journal-title":"Dev. Cell"},{"key":"10.1016\/j.ejphar.2026.179306_bib20","first-page":"647","article-title":"An integrative theory for cancer","volume":"43","author":"Luo","year":"2019","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.ejphar.2026.179306_bib21","doi-asserted-by":"crossref","first-page":"4411","DOI":"10.7150\/ijbs.81972","article-title":"RHOJ induces Epithelial-to-Mesenchymal transition by IL-6\/STAT3 to promote invasion and metastasis in gastric cancer","volume":"19","author":"Ma","year":"2023","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.ejphar.2026.179306_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-022-01259-6","article-title":"Targeting integrin pathways: mechanisms and advances in therapy","volume":"8","author":"Pang","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.ejphar.2026.179306_bib23","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1001\/jamaoto.2023.4322","article-title":"Head and neck cancer incidence in the United States before and during the COVID-19 pandemic","volume":"150","author":"Semprini","year":"2024","journal-title":"JAMA Otolaryngol. Head Neck Surg."},{"key":"10.1016\/j.ejphar.2026.179306_bib24","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202002163","article-title":"Nanotechnology-based strategies to evaluate and counteract cancer metastasis and neoangiogenesis","volume":"10","author":"\u015een","year":"2021","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.ejphar.2026.179306_bib25","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.cytogfr.2025.01.003","article-title":"Insights into IL-6\/JAK\/STAT3 signaling in the tumor microenvironment: implications for cancer therapy","volume":"85","author":"Thuya","year":"2025","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.ejphar.2026.179306_bib26","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13046-020-01760-2","article-title":"ASC-J9\u00ae suppresses prostate cancer cell proliferation and invasion via altering the ATF3-PTK2 signaling","volume":"40","author":"Tian","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.ejphar.2026.179306_bib28","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1111\/jop.13182","article-title":"Multiple tumour recurrence in oral, head and neck cancer: characterising the patient journey","volume":"50","author":"Wang","year":"2021","journal-title":"J. Oral Pathol. Med."},{"key":"10.1016\/j.ejphar.2026.179306_bib27","first-page":"2281","article-title":"LncRNA FEZF1-AS1 promoted chemoresistance, autophagy and epithelial-mesenchymal transition (EMT) through regulation of miR-25-3p\/ITGB8 axis in prostate cancer","volume":"24","author":"Wang","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2026.179306_bib29","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ajpath.2014.10.012","article-title":"Stromal androgen receptor roles in the development of normal prostate, benign prostate hyperplasia, and prostate cancer","volume":"185","author":"Wen","year":"2015","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ejphar.2026.179306_bib30","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/ijc.30446","article-title":"Sorafenib with ASC-J9(\u00ae) synergistically suppresses the HCC progression via altering the pSTAT3-CCL2\/Bcl2 signals","volume":"140","author":"Xu","year":"2017","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ejphar.2026.179306_bib31","doi-asserted-by":"crossref","first-page":"3818","DOI":"10.1158\/0008-5472.CAN-24-0067","article-title":"DAZAP1 phase separation regulates mitochondrial metabolism to facilitate invasion and metastasis of oral squamous cell carcinoma","volume":"84","author":"Zhang","year":"2024","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejphar.2026.179306_bib32","doi-asserted-by":"crossref","first-page":"6093","DOI":"10.1007\/s00210-024-03003-z","article-title":"ITGB6 promotes pancreatic fibrosis and aggravates the malignant process of pancreatic cancer via JAK2\/STAT3 signaling pathway","volume":"397","author":"Zhang","year":"2024","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926007880?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926007880?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T20:04:39Z","timestamp":1789070679000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299926007880"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":32,"alternative-id":["S0014299926007880"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.179306","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ASC-J9 attenuates the metastatic potential of oral cancer cells by downregulating the STAT3\/ITGB8 signaling pathway","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.179306","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"179306"}}